Final answer:
Anandamide and 2-Arachidonoylglycerol match with the drug THC, which acts as an agonist to cannabinoid receptors. Dopamine and serotonin are involved in different systems and are associated with drugs for treating disorders like Parkinson's and depression.
Step-by-step explanation:
The neurotransmitters Anandamide (A) and 2-Arachidonoylglycerol (2-AG) can be matched to the drug THC (Tetrahydrocannabinol) (1), which mimics the endogenous cannabinoids. Both of these neurotransmitters are part of the endocannabinoid system, which plays a role in regulating a variety of physiological and cognitive processes. THC, the main psychoactive compound found in cannabis, acts as an agonist to these cannabinoid receptors. Hence, we can establish the following matches:
- Anandamide (A) - THC (Tetrahydrocannabinol) (1)
- 2-Arachidonoylglycerol (2-AG) (B) - THC (Tetrahydrocannabinol) (1)
The other neurotransmitters and drugs listed, such as Dopamine (C), Serotonin (D), CBD (Cannabidiol) (2), MDMA (Ecstasy) (3), and SSRIs (Selective Serotonin Reuptake Inhibitors) (4), are associated with different systems or have different mechanisms of action. Dopamine is often targeted in conditions like Parkinson's disease with dopamine agonists, while SSRIs influence serotonin levels and are commonly prescribed for depression and anxiety disorders.